Torrent Pharmaceuticals Limited is expanding its voluntary recall from 2 lots of Losartan potassium tablets USP to a total of 10 lots, to the consumer level due to the detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient (API) manufactured by Hetero Labs Limited. Torrent is only recalling lots of losartan-containing products that contain N-nitrosodiethylamine (NDEA) above the acceptable daily intake levels released by the FDA. (US Food Recalls) More
Aurobindo expands recall of drug for impurities from US Daily News & Analysis
The nationwide voluntary recall of high blood pressure drug in the US by the Indian drug manufacturing companies continues as federal investigations ...
Posted on 5 March 2019 | 3:00 am | Google News
PITTSBURGH - Another day, another problem for blood pressure medications, and it's starting to frustrate Cindy Bryan who takes her pills daily. "Even the ...
Posted on 1 February 2019 | 3:00 am | Google News
Six Additional Lots of Losartan Tablets Recalled Pharmacy Times
Torrent Pharmaceuticals Limited has expanded its voluntary recall of Losartan potassium tablets USP to include 6 lots of Losartan potassium and ...
Posted on 23 January 2019 | 3:00 am | Google News
Torrent Pharmaceuticals Limited is expanding its voluntary recall from 10 lots of Losartan potassium tablets USP to include 6 lots of Losartan potassium and ...
Posted on 22 January 2019 | 3:00 am | Google News
Losartan Recall Expanded for Cancer-Causing Impurity Daily Hornet
A recent recall for the generic blood pressure medication Losartan has been expanded because it may contain a cancer-causing impurity.
Posted on 8 January 2019 | 3:00 am | Google News
8 New Lots of Losartan Potassium Tablets Added to Recall Contemporary Clinic
A recall of Torrent Pharmaceuticals Limited's Losartan Potassium Tablets USP has been expanded to include 8 additional lots.
Posted on 7 January 2019 | 12:55 pm | Google News
Copyright © 2019 LastMinuteStuff.com